Bioanalytical Systems, Inc. to Present at the 10th Annual Noble Financial Capital Markets Equity Conference Wednesday, January 22, 2014 at 10:00 a.m. EST Noble Financial Capital Markets Equity Conference 2014 Business Wire WEST LAFAYETTE, Ind. -- January 14, 2014 Bioanalytical Systems, Inc. (NASDAQ:BASI) announced today that it will make a presentation at the Tenth Annual Noble Financial Capital Markets Equity Conference on Wednesday, January 22, 2014 at 10:00 a.m. EST in Room 1 at the Club Med in Sandpiper Bay, Florida. You can access a live audio high-definition video of BASi's presentation and presentation materials online from the Investors tab at www.BASinc.com or at www.Noblefcm.com. The webcast requires the installation of Microsoft Silverlight viewer and will be available for replay at BASi's website for 90 days after the presentation. Please register for the webcast at least 10 minutes before the presentation begins. About Bioanalytical Systems, Inc. BASi is a pharmaceutical development company providing contract research services and monitoring instruments to the world's leading drug development companies and medical research organizations. The company focuses on developing innovative services and products that increase efficiency and reduce the cost of taking a new drug to market. Visit www.BASinc.com for more about BASi. About Noble Financial Noble Financial Capital Markets was established in 1984; 2014 marks its 30th Anniversary. Noble Financial is an equity research driven, full-service, investment banking boutique focused on life sciences, technology and media, emerging growth, companies. The company has offices in Boston, Los Angeles, and Boca Raton, FL. In addition to non-deal road shows and sector-specific conferences throughout the year, Noble Financial hosts its large format annual equity conference in January in South Florida featuring 120-150 presenting companies from across North America and total attendance of close to 600. For more information: www.noblefcm.com. This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to changes in the market and demand for our products and services, the development, marketing and sales of products and services, changes in technology, industry standards and regulatory standards, and various market and operating risks detailed in the company's filings with the Securities and Exchange Commission. Contact: Company Contact: Bioanalytical Systems, Inc. Jacqueline Lemke President, CEO and CFO 765-497-5829 jlemke@BASinc.com or Agency Contact: Berkman Associates Neil Berkman 310-477-3118 email@example.com
Bioanalytical Systems, Inc. to Present at the 10th Annual Noble Financial Capital Markets Equity Conference Wednesday, January
Press spacebar to pause and continue. Press esc to stop.